Clinical Trial Update: Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria. [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of the pediatric formulation of artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Coartem (artemether-lumefantrine)

Snippet

Sponsor: Novartis | Conditions: Malaria, Falciparum | Phase 3 | Status: COMPLETED